366 results on '"Sun, Bingjun"'
Search Results
2. Balancing efficacy and safety of doxorubicin-loaded albumin nanoparticles utilizing pH-sensitive doxorubicin-fatty acid prodrugs
3. Fine-tuning the structure-tolerance-antitumor efficacy axis of prodrug nanoassemblies via branched aliphatic functionalization
4. Erratum to: Balancing efficacy and safety of doxorubicin-loaded albumin nanoparticles utilizing pH-sensitive doxorubicin-fatty acid prodrugs
5. Reductants supplement boost the antitumor efficacy of nanomedicine
6. Optimizing structural design in SN38 delivery: More assembly stability and activation efficiency
7. Cholesterol sulfate-mediated ion-pairing facilitates the self-nanoassembly of hydrophilic cationic mitoxantrone
8. Dual role of triglyceride structures facilitates anti-tumor drug delivery: Both as a self-assembling module and a responsive module
9. Revealing the impact of modified modules flexibility on gemcitabine prodrug nanoassemblies for effective cancer therapy
10. Exploring the optimal chain length of modification module in disulfide bond bridged paclitaxel prodrug nanoassemblies for breast tumor treatment
11. Tailoring modification modules of paclitaxel prodrug nanoassemblies to manipulate efficacy and tolerance
12. Study on mechanical properties of shotcrete lattice girder in a tunnel considering the excavation effect at early-age
13. Elaboration a ROS-responsive darutigenol prodrug nanoassemblies for inflammatory arthritis treatment
14. Tetrasulfide bond boosts the anti-tumor efficacy of dimeric prodrug nanoassemblies
15. The effect of lengths of branched-chain fatty alcohols on the efficacy and safety of docetaxel-prodrug nanoassemblies
16. Rational engineering of cholesterol-modified prodrug nanoassemblies for improving the tumor selectivity and safety of mitoxantrone
17. Hybrid nanoassembly indicating a synthetic lethality relationship induces mitotic catastrophe-mediated tumor elimination
18. Bioorthogonal chemistry-driven anticancer nanotherapeutics
19. Cabazitaxel prodrug nanoassemblies with branched chain modifications: Narrowing the gap between efficacy and safety
20. Rational design of tumor-selective prodrug nanoassemblies: Greatly improving the in vivo fate and tolerability of high-toxic cabazitaxel
21. Precise engineering of disulfide bond-bridged prodrug nanoassemblies to balance antitumor efficacy and safety
22. Lymph node-targeting nanovaccines for cancer immunotherapy
23. Prodrug nanoassemblies bridged by Mono-/Di-/Tri-sulfide bonds: Exploration is for going further
24. Synergetic lethal energy depletion initiated by cancer cell membrane camouflaged nano-inhibitor for cancer therapy
25. Minor change in the length of carbon chain has a great influence on the antitumor effect of paclitaxel-fatty alcohol prodrug nanoassemblies: Small roles, big impacts
26. Iterative algorithm for the conformal mapping function from the exterior of a roadway to the interior of a unit circle
27. Hybrid chalcogen bonds in prodrug nanoassemblies provides dual redox-responsivity in the tumor microenvironment
28. Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy
29. Impact of the amount of PEG on prodrug nanoassemblies for efficient cancer therapy
30. Paclitaxel derivative-based liposomal nanoplatform for potentiated chemo-immunotherapy
31. Influence of anchorage length and pretension on the working resistance of rock bolt based on its tensile characteristics
32. Probing the Impact of Surface Functionalization Module on the Performance of Mitoxantrone Prodrug Nanoassemblies: Improving the Effectiveness and Safety
33. Iron-doxorubicin prodrug loaded liposome nanogenerator programs multimodal ferroptosis for efficient cancer therapy
34. Investigating the crucial roles of aliphatic tails in disulfide bond-linked docetaxel prodrug nanoassemblies
35. Erythrocyte membrane-camouflaged carrier-free nanoassembly of FRET photosensitizer pairs with high therapeutic efficiency and high security for programmed cancer synergistic phototherapy
36. Small changes in the length of diselenide bond-containing linkages exert great influences on the antitumor activity of docetaxel homodimeric prodrug nanoassemblies
37. Dimeric prodrug-based nanomedicines for cancer therapy
38. Nanotherapeutics for Antimetastatic Treatment
39. Ferroptosis-driven nanotherapeutics for cancer treatment
40. Binary prodrug nanoassemblies combining chemotherapy and ferroptosis activation for efficient triple-negative breast cancer therapy
41. Minor Changes in Response Modules Leading to a “U-Shaped” Conversion Rate of Docetaxel Prodrug Nanoassemblies
42. Satellite‐type Sulfur Atom Distribution in Trithiocarbonate Bond‐Bridged Dimeric Prodrug Nanoassemblies: Achieving Both Stability and Activatability
43. Molecularly engineered carrier-free co-delivery nanoassembly for self-sensitized photothermal cancer therapy
44. Redox dual-responsive paclitaxel-doxorubicin heterodimeric prodrug self-delivery nanoaggregates for more effective breast cancer synergistic combination chemotherapy
45. Integration of phospholipid-drug complex into self-nanoemulsifying drug delivery system to facilitate oral delivery of paclitaxel
46. Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy
47. Lossless Pruned Naive Bayes for Big Data Classifications
48. Fine-tuning the structure-tolerance-antitumor efficacy axis of prodrug nanoassemblies via branched aliphatic functionalization
49. Precisely albumin-hitchhiking tumor cell-activated reduction/oxidation-responsive docetaxel prodrugs for the hyperselective treatment of breast cancer
50. In Situ Sprayed Nanovaccine Suppressing Exosomal PD-L1 by Golgi Apparatus Disorganization for Postsurgical Melanoma Immunotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.